We are live on ! Find out more
AVXL icon

Anavex Life Sciences

146 hedge funds and large institutions have $161M invested in Anavex Life Sciences in 2024 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 51 increasing their positions, 43 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

228% more capital inflows, than outflows

Capital inflows: $45.1M | Capital outflows: $13.7M

19% more repeat investments, than reductions

Existing positions increased: 51 | Existing positions reduced: 43

7.22% more ownership

Funds ownership: 31.52% → 38.74% (+7.2%)

1% more call options, than puts

Call options by funds: $7.28M | Put options by funds: $7.19M

5% less funds holding

Funds holding: 153 → 146 (-7)

30% less first-time investments, than exits

New positions opened: 16 | Existing positions closed: 23

Holders
146
Holders Change
-7
Holders Change %
-4.58%
% of All Funds
2.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
51
Reduced
43
Closed
23
Calls
$7.28​M
Puts
$7.19​M
Net Calls
+$87​K
Net Calls Change
+$10.4​M

AVXL Hedge Fund Activity: Q1 2024 in Review

146 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in Anavex Life Sciences (AVXL) for Q1 2024, worth a combined $161M — down 33% from $241M a quarter earlier.

Sellers outnumbered buyers: 23 funds closed out of AVXL and 16 opened new positions — a net loss of 7 holders — while 43 trimmed existing stakes and 51 added.

The largest buyer was State Street, adding an estimated $20.6M. The largest seller was SG Americas Securities, exiting entirely with an estimated $2.86M sold.

  • 146 institutional investors held Anavex Life Sciences (AVXL) as of Q1 2024, down from 153 in Q4 2023.
  • Funds reported $161M of Anavex Life Sciences stock for Q1 2024, down 33% quarter-over-quarter.
  • 16 funds opened new Anavex Life Sciences positions in Q1 2024 and 23 closed out, a net change of -7 holders.
  • The largest Anavex Life Sciences buyer in Q1 2024 was State Street, an estimated $20.6M added.
  • The largest Anavex Life Sciences seller in Q1 2024 was SG Americas Securities, an estimated $2.86M sold.

Based on aggregated 13F filings for Q1 2024.